Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy
出版年份 2014 全文链接
标题
Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy
作者
关键词
-
出版物
FEBS LETTERS
Volume 588, Issue 16, Pages 2616-2621
出版商
Wiley
发表日期
2014-05-17
DOI
10.1016/j.febslet.2014.05.008
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway
- (2014) Min Lu et al. CELL
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
- (2013) Z. Y. Xu-Monette et al. BLOOD
- Directed Phenotype Switching as an Effective Antimelanoma Strategy
- (2013) Magalí Sáez-Ayala et al. CANCER CELL
- Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
- (2013) Min Lu et al. CANCER CELL
- DNp73 Exerts Function in Metastasis Initiation by Disconnecting the Inhibitory Role of EPLIN on IGF1R-AKT/STAT3 Signaling
- (2013) Marc Steder et al. CANCER CELL
- BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
- (2013) V. J. Mar et al. CLINICAL CANCER RESEARCH
- p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
- (2013) Rubeta N. Matin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impaired PIASy–Tip60 signaling weakens activation of p53 in melanoma
- (2013) Alexander J. Lakhter et al. MELANOMA RESEARCH
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
- (2013) Liz J. Valente et al. Cell Reports
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
- (2012) Tongyuan Li et al. CELL
- MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop
- (2012) Tobias Sinnberg et al. EXPERIMENTAL DERMATOLOGY
- MEK'ing the Most of p53 Reactivation Therapy in Melanoma
- (2012) John T. Lee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Role of Tip60 in Human Melanoma Cell Migration, Metastasis, and Patient Survival
- (2012) Guangdi Chen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Structural Basis for ASPP2 Recognition by the Tumor Suppressor p73
- (2012) Peter Canning et al. JOURNAL OF MOLECULAR BIOLOGY
- MDM4 is a key therapeutic target in cutaneous melanoma
- (2012) Agnieszka Gembarska et al. NATURE MEDICINE
- RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
- (2012) Fei Su et al. NEW ENGLAND JOURNAL OF MEDICINE
- Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells
- (2011) E. Rudolf et al. APOPTOSIS
- P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
- (2011) Kelly A Avery-Kiejda et al. BMC CANCER
- Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
- (2011) Colleen A. Brady et al. CELL
- iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe
- (2011) L. Jiang et al. CLINICAL CANCER RESEARCH
- Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma
- (2011) J de Lange et al. ONCOGENE
- Abnormal MDMX degradation in tumor cells due to ARF deficiency
- (2011) X Li et al. ONCOGENE
- Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification
- (2011) M. Notari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance to MEK Inhibitors: Should We Co-Target Upstream?
- (2011) P. I. Poulikakos et al. Science Signaling
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
- (2010) Tamara Terzian et al. Pigment Cell & Melanoma Research
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes
- (2009) Hong Yu et al. AMERICAN JOURNAL OF PATHOLOGY
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy
- (2008) H. S. Bell et al. CANCER RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- A complex barcode underlies the heterogeneous response of p53 to stress
- (2008) Fiona Murray-Zmijewski et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53
- (2008) Arnold J. Levine VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started